CoChat

Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke

Open access
Derby, Laura E., Myers, Marian W., Jick, Hershel · 1999 · British Journal of Clinical Pharmacology
Cited by 34

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aims To estimate the incidence of newly diagnosed idiopathic stroke among users of fenfluramine, dexfenfluramine and phentermine compared to obese nonusers. Methods We conducted a cohort study with nested case‐control analysis utilizing data from the General Practice Research Database in the UK. Eight thousand four hundred and twenty‐three subjects aged 69 years or less at the start of follow‐up were exposed to at least one of the three study drugs and 17 225 similarly obese subjects were not exposed to any of the study drugs. Results We identified 45 incident cases of idiopathic CVA in this cohort of subjects. The incidence of CVA among all current users of a diet drug was 1.3/1000 person‐years (95% CI 0.5, 3.5). The incidence for current fenfluramine users (n=2) was 2.6/1000 person‐years (95% CI 0.7, 9.6), for current dexfenfluramine users (n=1) 1.1/1000 person‐years (95% CI 0.3, 3.8), and for current phentermine users 0/1000 person‐years (95% CI 0.0, 12.9). The incidence in obese nonusers was 0.6/1000 person‐years (95% CI 0.4, 0.9). The adjusted matched odds ratio (OR) for thrombotic stroke from the case‐control analysis comparing current use of a diet drug to nonuse was 2.4 (95% CI 0.6, 9.1). There was only one exposed subject among seven who had haemorrhagic stroke. Conclusions The incidence of CVA in generally young obese subjects during use of fenfluramine, dexfenfluramine or phentermine is low. Although we found an OR of 2.4 comparing users of any of the anorexiants with nonusers, this is based on only three exposed cases and the confidence limits are wide. We conclude that our study does not support a substantial increased risk of stroke attributable to the use of fenfluramine, dexfenfluramine or phentermine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2125.1999.00928.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 34

Metadata

Authors
Derby, L. E., Myers, M. W., & Jick, H.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
1999-05
Volume
47
Issue
5
Pages
565-569
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1643550007
Cited by
34
References
3
FWCI
0.20
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. https://app.cochat.ai/papers/10.1046/j.1365-2125.1999.00928.x
The paper
Derby, L. E., Myers, M. W., & Jick, H. (1999). Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1999.00928.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.